Cytokinetics | CYTK - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Acadia Pharmaceuticals USD 3.64M 269.93M 2026-03
Amgen USD 1.82B 486M 2026-03
Arca Biopharma USD -29.58M 694K 2025-12
Bayer EUR 2.76B 6.52B 2026-03
Biogen USD 319.5M 368.4M 2026-03
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Eisai JPY -3.25B 20.43B 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Exelixis USD 210.47M 34.06M 2026-03
Geron USD -3.64M 27.5M 2026-03
Halozyme Therapeutics USD 150.05M 291.64M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
Ligand Pharmaceuticals USD -13.34M 58.13M 2026-03
Merck USD -4.24B 7.2B 2026-03
Novartis USD 3.16B 747M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03